Article Data

  • Views 521
  • Dowloads 115

Original Research

Open Access

The role of appendectomy as part of the treatment of a mucinous borderline ovarian tumor

  • S. Cosyns1,*,
  • N.P. Polyzos1
  • M. Carprieaux1
  • H. Tournaye1
  • P. De Sutter1

1 UZBrussel University Hospital, Brussels, Belgium

DOI: 10.12892/ejgo2802.2016 Vol.37,Issue 2,April 2016 pp.167-170

Published: 10 April 2016

*Corresponding Author(s): S. Cosyns E-mail:


Guidelines in surgical treatment of mucinous ovarian neoplasms recommend the use of appendectomy as a measure to rule out a primary appendiceal origin of the ovarian tumor and proper staging. In extension this guideline is also applied for mucinous borderline ovarian tumors (mBOTs). As borderline ovarian tumors (BOTs) are often diagnosed postoperatively, most patients must undergo a second surgery to add appendectomy and staging to their surgical treatment. Objective: To assess the role of appendectomy as part of the surgical treatment of mucinous BOTs. Materials and Methods: A retrospective single institute based study was carried out. The authors evaluated the clinical charts of patients undergoing surgical treatment by a gynecologic oncologist in their institution for a mucinous BOT between January 1990 and January 2014. Results: Twenty-seven patients were included. Appendectomy was performed in 30% of patients during primary or secondary surgical treatment. No appendiceal carcinoma was identified in any of the cases. Five patients already had a previous appendectomy. In eight patients the appendix was described as normal during surgery and left in place. For six patients the authors did not retrieve any information on previous appendectomy neither on the intraoperative state of the appendix. In the present overall study population, 78% showed no appendiceal involvement. For the remaining patients this information was missing. Conclusions: Secondary appendectomy to rule out a primary appendiceal origin of the mucinous BOT should not be performed when the appendix is described as grossly normal during primary laparoscopic surgery.


Mucinous borderline ovarian tumor; Low malignant potential; Appendectomy; Restaging; Laparoscopy.

Cite and Share

S. Cosyns,N.P. Polyzos,M. Carprieaux,H. Tournaye,P. De Sutter. The role of appendectomy as part of the treatment of a mucinous borderline ovarian tumor. European Journal of Gynaecological Oncology. 2016. 37(2);167-170.


[1] Hart W.R.: “Borderline epithelial tumors of the ovary”. Mod. Pathol., 2005, 18, 33.

[2] NCCN Clinical Practice Guidelines in Oncology: “Ovarian Cancer. V2.2010. p MS-1”. Available at:


[4] Lin J.E., Seo S., Kushner D.M., Rose S.L.: “The role of appendectomy for mucinous ovarian neoplasms”. Am. J. Obstet. Gynecol., 2013, 208, 46.e1

[5] Timofeev J., Galgano M.T., Stoler M.H., Lachance J.A., Modesitt S.C., Jazaeri A.A.: “Appendiceal pathology at the time of oophorectomy for ovarian neoplasms”. Obstet. Gynecol., 2010, 116, 1348.

[6] Medeiros L.R., Rosa D.D., Edelweiss M.I., Stein A.T., Bozzetti M.C., Zelmanowicz A., et al.: “Accuracy of frozen-section analysis in the diagnosis of ovarian tumors: a systematic quantitative review”. Int. J. Gynecol, Cancer, 2005, 15, 192.

[7] Gultekin E., Gultekin O.E., Cingillioglu B., Sayhan S., Sanci M., Yildirim Y.: “The value of frozen section evaluation in the management of borderline ovarian tumors”. J. Cancer Res. Ther., 2011, 7, 416.

[8] Rose P.G., Reale F.R., Fisher A., Hunter R.E.: “Appendectomy in primary and secondary staging operations for ovarian malignancy”. Obstet. Gynecol., 1991, 77, 116.

[9] Ayhan A., Tuncer Z.S., Tuncer R., Yüce K., Ayhan A.: “Is routine appendectomy beneficial in the management of ovarian cancer?” Eur. J. Obstet. Gynecol. Reprod. Biol., 1994, 57, 29.

[10] Lee C.H., Kim M.K., Roh J.W., Kim J.W., Park N.H., Min E.G.: “Appendectomy for patients presenting with epithelial ovarian cancer apparently confined to the pelvis: To do or not to do?” J. Womens Health, 2010, 3, 3.

[11] Ayhan A., Gultekin M., Taskiran C., Salman M.C., Celik N.Y., Yuce K., et al.: “Routine appendectomy in epithelial ovarian carcinoma: is it necessary?” Obstet. Gynecol., 2005, 105, 719.

[12] Fontanelli R., Paladini D., Raspagliesi F., di Re E.: “The role of appendectomy in surgical procedures for ovarian cancer”. Gynecol. Oncol., 1992, 46, 42.

[13] Ramirez P.T., Slomovitz B.M., McQuinn L., Levenback C., Coleman R.L.: “Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer”. Gynecol. Oncol., 2006, 103, 888.

[14] Lin J.E., Seo S., Kushner D.M., Rose S.L.: “The role of appendectomy for mucinous ovarian neoplasms”. Am. J. Obstet. Gynecol., 2013, 208, 46.e1.

[15] Feigenberg T., Covens A., Ghorab Z., Ismiil N., Dubé V., Saad R.S., et al.: “Is routine appendectomy at the time of primary surgery for mucinous ovarian neoplasms beneficial?” Int. J. Gynecol. Cancer, 2013, 23, 1205.

[16] Koskas M., Uzan C., Gouy S., Pautier P., Lhommé C., Haie-Meder C., et al.: “Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma)”. Ann. Surg. Oncol., 2011, 18, 40.

[17] Kleppe M., Bruls J., Van Gorp T., Massuger L., Slangen B.F., Van de Vijver K.K., et al.: “Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature”. Gynecol. Oncol., 2014, 133, 155.

[18] Song T., Choi C.H., Kim H.J., Kim M.K., Kim T.J., Lee J.W., et al.: “Accuracy of frozen section diagnosis of borderline ovarian tumors”. Gynecol. Oncol., 2011, 122, 127.

[19] Tempfer C.B., Polterauer S., Bentz E.K., Reinthaller A., Hefler L.A.: “Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary: a retrospective analysis of 96 cases and review of the literature”. Gynecol. Oncol., 2007, 107, 248.

[20] Fauvet R., Boccara J., Dufournet C., David-Montefiore E., Poncelet C., Daraï E.: “Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study”. Cancer, 2004, 100, 1145.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time